Managing pregnancy in inflammatory rheumatological diseases.

Varsha Jain, Caroline Gordon

Research output: Contribution to journalArticle

28 Citations (Scopus)


ABSTRACT: Historically, pregnancy in women with many inflammatory rheumatic diseases was not considered safe and was discouraged. Combined care allows these pregnancies to be managed optimally, with the majority of outcomes being favorable. Disease activity at the time of conception and anti-phospholipid antibodies are responsible for most complications. Disease flares, pre-eclampsia, and thrombosis are the main maternal complications, whereas fetal loss and intrauterine growth restriction are the main fetal complications. Antirheumatic drugs used during pregnancy and lactation to control disease activity are corticosteroids, hydroxychloroquine, sulphasalzine, and azathioprine. Vaginal delivery is possible in most circumstances, with cesarean section being reserved for complications.
Original languageEnglish
Pages (from-to)206
Number of pages1
JournalArthritis Research & Therapy
Issue number1
Publication statusPublished - 25 Feb 2011


Dive into the research topics of 'Managing pregnancy in inflammatory rheumatological diseases.'. Together they form a unique fingerprint.

Cite this